Acoustic and surface EMG diagnosis of pediatric muscle disease

D T Barry1, K E Gordon, G G Hinton

  • 1Department of Physical Medicine and Rehabilitation, University of Michigan Medical Center, Ann Arbor 48109-0042.

Muscle & Nerve
|April 1, 1990
PubMed

Insights

The ratio of acoustic myography (AMG) to surface electromyography (EMG) amplitude effectively distinguishes muscle disease in children. This non-invasive method shows significant diagnostic potential for pediatric neuromuscular conditions.

Area of Science:

  • Biomedical Engineering
  • Neurology
  • Pediatrics

Background:

  • Assessing muscle mechanical output relative to electrical activity is crucial for diagnosing neuromuscular disorders.
  • Surface electromyography (sEMG) measures electrical activity, but a direct measure of mechanical output is needed for comprehensive assessment.

Purpose of the Study:

  • To evaluate the ratio of acoustic myography (AMG) amplitude to surface electromyography (EMG) amplitude as a diagnostic marker for muscle disease in children.
  • To compare AMG/EMG ratios in children with muscle disease to those in healthy children.

Main Methods:

  • AMG and EMG amplitudes were recorded from 16 children diagnosed with muscle disease and 11 healthy children (ages 7-16).
  • A linear discriminant function was used to establish normal AMG/EMG ratio ranges.
  • Diagnostic accuracy was assessed using sensitivity and specificity.

Main Results:

  • A significant difference (P < 0.01) was observed in AMG/EMG ratios between children with muscle disease and healthy controls.
  • The linear discriminant function achieved 82% sensitivity and 91% specificity in diagnosing muscle disease.
  • These findings indicate the potential of surface recordings for diagnosing muscle conditions.

Conclusions:

  • The AMG/EMG amplitude ratio is a promising, non-invasive tool for diagnosing muscle disease in children.
  • Surface recordings, particularly when combined with additional muscles or evoked twitches, may enhance diagnostic accuracy for pediatric neuromuscular conditions.